ATX's Principal Activity is the development of its Focal Adhesion Kinase inhibiting ("FAKi") drug candidates AMP886 and AMP945.
Last (Price) | |
Change | 0.00 (0.00) |
Bid / Ask | - |
Volume | |
Volume (4w avg) | |
Turnover | |
Open | |
Day Range | - |
VWAP | |
Prev Close | |
Last Trade |
1 Week | |
1 Month | |
2021 YTD | |
1 Year | |
vs Sector (1yr) | +321.57% |
vs ASX 200 (1yr) | +284.35% |
Market Capitalisation | |
ASX Rank | 1649 of 2,556 |
Sector Rank | 145 of 177 |
Date | Heading | Pages | File Size | Time |
---|---|---|---|---|
Amplia Therapeutics Limited (ATX, formerly Innate Immunotherapeutics Limited) is an Australian pharmaceutical company that is advancing a pipeline of Focal Adhesion Kinase (FAK) inhibitors for cancer and fibrosis. FAK is an increasingly important target in the field of cancer immunology and Amplia has a particular development focus in pancreatic and ovarian cancer. FAK also plays a significant role in a number of chronic diseases, such as idiopathic pulmonary fibrosis (IPF).
No incorporation details available.
Head Office | Melbourne VIC 3000 |
Website | www.ampliatx.com |
Registry | Computershare |
Auditor | Grant Thornton Audit Pty Ltd |
Date Listed | 23 Dec 2013 |
Date | Event |
---|---|
28/05/2021 | Report (Prelim) |
30/07/2021 | Report (Annual) |
26/11/2021 | Report (Interim) |
See Upcoming Dividends for all ASX companies.
ATX directors must report any change in shareholding to the ASX within 5 business days.
See Director Transactions for all ASX companies.
The current holdings of ATX directors.
A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.
Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.
Name | Last Notice | Total Shares | Shares Held (%) |
---|---|---|---|
CTx CRC Ltd | 14/07/2020 | 4,514,468 | 5.23 |
Platinum Investment Management Limited | 04/08/2020 | 17,169,000 | 16.15 |
Blueflag Holdings Pty Ltd | 04/08/2020 | 7,500,000 | 7.06 |
12 month transaction history compiled from ASX announcements.
Date | Name | Bought | Previous % | New % |
---|---|---|---|---|
14-07-20 | Blueflag Holdings Pty Ltd | 7,500,000 | -- | 8.69 |
10-07-20 | Platinum Investment Management Limited | 11,454,000 | 8.60 | 19.89 |
12 month transaction history compiled from ASX announcements.
No sell transactions reported by Substantial Shareholders in the past 12 months.
Date | Close | Change | %Chg | Open | High | Low | Volume | Turnover |
---|---|---|---|---|---|---|---|---|
Year | Closing Price | Last Trade |
---|---|---|
2020 | $0.125 | 30 June |
2019 | $0.097 | 28 June |
All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.